ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
2
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
2
U.S. (TOLL FREE)
+1 (315) 215-3225
Global PD-L1 and PIK3CA Testing Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-8D9429
Home | Market Reports | Health| Medical Facilities & Services| Medical Procedures
Global PD L1 and PIK3CA Testing Market Insights and Forecast to 2028
BUY CHAPTERS

Global PD-L1 and PIK3CA Testing Market Research Report 2025

Code: QYRE-Auto-8D9429
Report
August 2025
Pages:76
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Agilent Technologies
Roche
Qiagen NV
EntroGen
Amoy Diagnostics
ACCB Biotech

PD-L1 and PIK3CA Testing Market Size

The global market for PD-L1 and PIK3CA Testing was valued at US$ 870 million in the year 2024 and is projected to reach a revised size of US$ 2650 million by 2031, growing at a CAGR of 16.9% during the forecast period.

PD-L1 and PIK3CA Testing Market

PD-L1 and PIK3CA Testing Market

PD-L1 Biomarker Testing measures the amount of PDL1 on cancer cells. PDL1 is a protein that helps keep immune cells from attacking nonharmful cells in the body. Normally, the immune system fights foreign substances like viruses and bacteria, and not your own healthy cells. Some cancer cells have high amounts of PDL1. This allows the cancer cells to "trick" the immune system, and avoid being attacked as foreign, harmful substances. Current PD-L1 testing is based on immunohistochemistry (IHC) methods. Immunohistochemistry (IHC) is the process whereby antibodies are used to detect proteins (antigens) in cells within a tissue section (for instance liver, pancreas or the heart). PD-L1 is a ligand that binds to PD-1 (programmed cell death-1), expressed on activated T cells, to evade anti-tumor responses. PD-L1 plays a role in inhibiting T cell activation and proliferation and has emerged as an important target in cancer treatment. PD-L1 protein detection by immunohistochemistry (IHC) testing is widely used as a predictive biomarker assay for anti–PD-1/PD-L1 therapies. PIK3CA is a gene that encodes a lipid kinase involved in multiple signaling pathways. These pathways influence cellular functions such as growth, death, and proliferation. PIK3CA mutations activate the PI3K-PTEN-AKT pathway, which is downstream from both the EGFR and the RAS-RAF-MAPK pathways. PIK3CA mutations may cause oncogenic transformation independent of RAS or RAF mutations. PIK3CA mutations occur in about 15% to 30% of breast, endometrial, and colon cancers. They occur less frequently in lung cancer and other types of cancer. Presence of PIK3CA mutations is associated with poor prognosis and lack of response to specific therapies in patients with breast, endometrial, or colon cancer.
The global PD-L1 and PIK3CA testing market is experiencing robust growth, driven by the expanding use of precision oncology and the approval of targeted therapies across various cancer types, including NSCLC, breast, and cervical cancers. The increasing demand for companion diagnostics (CDx) in tandem with immunotherapies and PI3K inhibitors is accelerating the adoption of PD-L1 IHC assays and PIK3CA mutation tests. Additionally, government-backed initiatives for cancer screening, advancements in next-generation sequencing (NGS) platforms, and the growing integration of biomarkers into clinical decision-making are fostering greater clinical reliance on these tests. Leading pharmaceutical companies are also investing heavily in clinical trials that necessitate biomarker-based patient stratification, further boosting market penetration.
Despite the growth, the PD-L1 and PIK3CA testing market faces several challenges. Variability in test interpretation, lack of assay standardization, and the complexity of tumor heterogeneity often lead to inconsistent clinical outcomes, hampering trust in testing results. Regulatory hurdles for companion diagnostics, especially in emerging markets, and the high cost of NGS-based platforms pose barriers to adoption. Moreover, reimbursement uncertainty and disparities in healthcare infrastructure limit access in low-to-middle-income regions. The market is also affected by the evolving landscape of oncology diagnostics, where novel biomarkers and multi-gene panels may shift clinical focus away from single-analyte tests like PD-L1 or PIK3CA.
This report aims to provide a comprehensive presentation of the global market for PD-L1 and PIK3CA Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PD-L1 and PIK3CA Testing.
The PD-L1 and PIK3CA Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global PD-L1 and PIK3CA Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the PD-L1 and PIK3CA Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of PD-L1 and PIK3CA Testing Market Report

Report Metric Details
Report Name PD-L1 and PIK3CA Testing Market
Accounted market size in year US$ 870 million
Forecasted market size in 2031 US$ 2650 million
CAGR 16.9%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • PD-L1 Testing
  • PIK3CA Testing
Segment by Application
  • Hospital
  • Diagnostic Center
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Agilent Technologies, Roche, QIAGEN, EntroGen, Amoy Diagnostics, ACCB Biotech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of PD-L1 and PIK3CA Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is PD-L1 and PIK3CA Testing Market growing?

Ans: The PD-L1 and PIK3CA Testing Market witnessing a CAGR of 16.9% during the forecast period 2025-2031.

What is the PD-L1 and PIK3CA Testing Market size in 2031?

Ans: The PD-L1 and PIK3CA Testing Market size in 2031 will be US$ 2650 million.

Who are the main players in the PD-L1 and PIK3CA Testing Market report?

Ans: The main players in the PD-L1 and PIK3CA Testing Market are Agilent Technologies, Roche, QIAGEN, EntroGen, Amoy Diagnostics, ACCB Biotech

What are the Application segmentation covered in the PD-L1 and PIK3CA Testing Market report?

Ans: The Applications covered in the PD-L1 and PIK3CA Testing Market report are Hospital, Diagnostic Center, Others

What are the Type segmentation covered in the PD-L1 and PIK3CA Testing Market report?

Ans: The Types covered in the PD-L1 and PIK3CA Testing Market report are PD-L1 Testing, PIK3CA Testing

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global PD-L1 and PIK3CA Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 PD-L1 Testing
1.2.3 PIK3CA Testing
1.3 Market by Application
1.3.1 Global PD-L1 and PIK3CA Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Diagnostic Center
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global PD-L1 and PIK3CA Testing Market Perspective (2020-2031)
2.2 Global PD-L1 and PIK3CA Testing Growth Trends by Region
2.2.1 Global PD-L1 and PIK3CA Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 PD-L1 and PIK3CA Testing Historic Market Size by Region (2020-2025)
2.2.3 PD-L1 and PIK3CA Testing Forecasted Market Size by Region (2026-2031)
2.3 PD-L1 and PIK3CA Testing Market Dynamics
2.3.1 PD-L1 and PIK3CA Testing Industry Trends
2.3.2 PD-L1 and PIK3CA Testing Market Drivers
2.3.3 PD-L1 and PIK3CA Testing Market Challenges
2.3.4 PD-L1 and PIK3CA Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top PD-L1 and PIK3CA Testing Players by Revenue
3.1.1 Global Top PD-L1 and PIK3CA Testing Players by Revenue (2020-2025)
3.1.2 Global PD-L1 and PIK3CA Testing Revenue Market Share by Players (2020-2025)
3.2 Global Top PD-L1 and PIK3CA Testing Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by PD-L1 and PIK3CA Testing Revenue
3.4 Global PD-L1 and PIK3CA Testing Market Concentration Ratio
3.4.1 Global PD-L1 and PIK3CA Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by PD-L1 and PIK3CA Testing Revenue in 2024
3.5 Global Key Players of PD-L1 and PIK3CA Testing Head office and Area Served
3.6 Global Key Players of PD-L1 and PIK3CA Testing, Product and Application
3.7 Global Key Players of PD-L1 and PIK3CA Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 PD-L1 and PIK3CA Testing Breakdown Data by Type
4.1 Global PD-L1 and PIK3CA Testing Historic Market Size by Type (2020-2025)
4.2 Global PD-L1 and PIK3CA Testing Forecasted Market Size by Type (2026-2031)
5 PD-L1 and PIK3CA Testing Breakdown Data by Application
5.1 Global PD-L1 and PIK3CA Testing Historic Market Size by Application (2020-2025)
5.2 Global PD-L1 and PIK3CA Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America PD-L1 and PIK3CA Testing Market Size (2020-2031)
6.2 North America PD-L1 and PIK3CA Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America PD-L1 and PIK3CA Testing Market Size by Country (2020-2025)
6.4 North America PD-L1 and PIK3CA Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe PD-L1 and PIK3CA Testing Market Size (2020-2031)
7.2 Europe PD-L1 and PIK3CA Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe PD-L1 and PIK3CA Testing Market Size by Country (2020-2025)
7.4 Europe PD-L1 and PIK3CA Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific PD-L1 and PIK3CA Testing Market Size (2020-2031)
8.2 Asia-Pacific PD-L1 and PIK3CA Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific PD-L1 and PIK3CA Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific PD-L1 and PIK3CA Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America PD-L1 and PIK3CA Testing Market Size (2020-2031)
9.2 Latin America PD-L1 and PIK3CA Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America PD-L1 and PIK3CA Testing Market Size by Country (2020-2025)
9.4 Latin America PD-L1 and PIK3CA Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa PD-L1 and PIK3CA Testing Market Size (2020-2031)
10.2 Middle East & Africa PD-L1 and PIK3CA Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa PD-L1 and PIK3CA Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa PD-L1 and PIK3CA Testing Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Agilent Technologies
11.1.1 Agilent Technologies Company Details
11.1.2 Agilent Technologies Business Overview
11.1.3 Agilent Technologies PD-L1 and PIK3CA Testing Introduction
11.1.4 Agilent Technologies Revenue in PD-L1 and PIK3CA Testing Business (2020-2025)
11.1.5 Agilent Technologies Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche PD-L1 and PIK3CA Testing Introduction
11.2.4 Roche Revenue in PD-L1 and PIK3CA Testing Business (2020-2025)
11.2.5 Roche Recent Development
11.3 QIAGEN
11.3.1 QIAGEN Company Details
11.3.2 QIAGEN Business Overview
11.3.3 QIAGEN PD-L1 and PIK3CA Testing Introduction
11.3.4 QIAGEN Revenue in PD-L1 and PIK3CA Testing Business (2020-2025)
11.3.5 QIAGEN Recent Development
11.4 EntroGen
11.4.1 EntroGen Company Details
11.4.2 EntroGen Business Overview
11.4.3 EntroGen PD-L1 and PIK3CA Testing Introduction
11.4.4 EntroGen Revenue in PD-L1 and PIK3CA Testing Business (2020-2025)
11.4.5 EntroGen Recent Development
11.5 Amoy Diagnostics
11.5.1 Amoy Diagnostics Company Details
11.5.2 Amoy Diagnostics Business Overview
11.5.3 Amoy Diagnostics PD-L1 and PIK3CA Testing Introduction
11.5.4 Amoy Diagnostics Revenue in PD-L1 and PIK3CA Testing Business (2020-2025)
11.5.5 Amoy Diagnostics Recent Development
11.6 ACCB Biotech
11.6.1 ACCB Biotech Company Details
11.6.2 ACCB Biotech Business Overview
11.6.3 ACCB Biotech PD-L1 and PIK3CA Testing Introduction
11.6.4 ACCB Biotech Revenue in PD-L1 and PIK3CA Testing Business (2020-2025)
11.6.5 ACCB Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Agilent Technologies
Roche
Qiagen NV
EntroGen
Amoy Diagnostics
ACCB Biotech
List of Tables
 Table 1. Global PD-L1 and PIK3CA Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of PD-L1 Testing
 Table 3. Key Players of PIK3CA Testing
 Table 4. Global PD-L1 and PIK3CA Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global PD-L1 and PIK3CA Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global PD-L1 and PIK3CA Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global PD-L1 and PIK3CA Testing Market Share by Region (2020-2025)
 Table 8. Global PD-L1 and PIK3CA Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global PD-L1 and PIK3CA Testing Market Share by Region (2026-2031)
 Table 10. PD-L1 and PIK3CA Testing Market Trends
 Table 11. PD-L1 and PIK3CA Testing Market Drivers
 Table 12. PD-L1 and PIK3CA Testing Market Challenges
 Table 13. PD-L1 and PIK3CA Testing Market Restraints
 Table 14. Global PD-L1 and PIK3CA Testing Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global PD-L1 and PIK3CA Testing Market Share by Players (2020-2025)
 Table 16. Global Top PD-L1 and PIK3CA Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-L1 and PIK3CA Testing as of 2024)
 Table 17. Ranking of Global Top PD-L1 and PIK3CA Testing Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by PD-L1 and PIK3CA Testing Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of PD-L1 and PIK3CA Testing, Headquarters and Area Served
 Table 20. Global Key Players of PD-L1 and PIK3CA Testing, Product and Application
 Table 21. Global Key Players of PD-L1 and PIK3CA Testing, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global PD-L1 and PIK3CA Testing Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global PD-L1 and PIK3CA Testing Revenue Market Share by Type (2020-2025)
 Table 25. Global PD-L1 and PIK3CA Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global PD-L1 and PIK3CA Testing Revenue Market Share by Type (2026-2031)
 Table 27. Global PD-L1 and PIK3CA Testing Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global PD-L1 and PIK3CA Testing Revenue Market Share by Application (2020-2025)
 Table 29. Global PD-L1 and PIK3CA Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global PD-L1 and PIK3CA Testing Revenue Market Share by Application (2026-2031)
 Table 31. North America PD-L1 and PIK3CA Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America PD-L1 and PIK3CA Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America PD-L1 and PIK3CA Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe PD-L1 and PIK3CA Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe PD-L1 and PIK3CA Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe PD-L1 and PIK3CA Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific PD-L1 and PIK3CA Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific PD-L1 and PIK3CA Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific PD-L1 and PIK3CA Testing Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America PD-L1 and PIK3CA Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America PD-L1 and PIK3CA Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America PD-L1 and PIK3CA Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa PD-L1 and PIK3CA Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa PD-L1 and PIK3CA Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa PD-L1 and PIK3CA Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Agilent Technologies Company Details
 Table 47. Agilent Technologies Business Overview
 Table 48. Agilent Technologies PD-L1 and PIK3CA Testing Product
 Table 49. Agilent Technologies Revenue in PD-L1 and PIK3CA Testing Business (2020-2025) & (US$ Million)
 Table 50. Agilent Technologies Recent Development
 Table 51. Roche Company Details
 Table 52. Roche Business Overview
 Table 53. Roche PD-L1 and PIK3CA Testing Product
 Table 54. Roche Revenue in PD-L1 and PIK3CA Testing Business (2020-2025) & (US$ Million)
 Table 55. Roche Recent Development
 Table 56. QIAGEN Company Details
 Table 57. QIAGEN Business Overview
 Table 58. QIAGEN PD-L1 and PIK3CA Testing Product
 Table 59. QIAGEN Revenue in PD-L1 and PIK3CA Testing Business (2020-2025) & (US$ Million)
 Table 60. QIAGEN Recent Development
 Table 61. EntroGen Company Details
 Table 62. EntroGen Business Overview
 Table 63. EntroGen PD-L1 and PIK3CA Testing Product
 Table 64. EntroGen Revenue in PD-L1 and PIK3CA Testing Business (2020-2025) & (US$ Million)
 Table 65. EntroGen Recent Development
 Table 66. Amoy Diagnostics Company Details
 Table 67. Amoy Diagnostics Business Overview
 Table 68. Amoy Diagnostics PD-L1 and PIK3CA Testing Product
 Table 69. Amoy Diagnostics Revenue in PD-L1 and PIK3CA Testing Business (2020-2025) & (US$ Million)
 Table 70. Amoy Diagnostics Recent Development
 Table 71. ACCB Biotech Company Details
 Table 72. ACCB Biotech Business Overview
 Table 73. ACCB Biotech PD-L1 and PIK3CA Testing Product
 Table 74. ACCB Biotech Revenue in PD-L1 and PIK3CA Testing Business (2020-2025) & (US$ Million)
 Table 75. ACCB Biotech Recent Development
 Table 76. Research Programs/Design for This Report
 Table 77. Key Data Information from Secondary Sources
 Table 78. Key Data Information from Primary Sources
 Table 79. Authors List of This Report


List of Figures
 Figure 1. PD-L1 and PIK3CA Testing Picture
 Figure 2. Global PD-L1 and PIK3CA Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global PD-L1 and PIK3CA Testing Market Share by Type: 2024 VS 2031
 Figure 4. PD-L1 Testing Features
 Figure 5. PIK3CA Testing Features
 Figure 6. Global PD-L1 and PIK3CA Testing Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global PD-L1 and PIK3CA Testing Market Share by Application: 2024 VS 2031
 Figure 8. Hospital Case Studies
 Figure 9. Diagnostic Center Case Studies
 Figure 10. Others Case Studies
 Figure 11. PD-L1 and PIK3CA Testing Report Years Considered
 Figure 12. Global PD-L1 and PIK3CA Testing Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global PD-L1 and PIK3CA Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global PD-L1 and PIK3CA Testing Market Share by Region: 2024 VS 2031
 Figure 15. Global PD-L1 and PIK3CA Testing Market Share by Players in 2024
 Figure 16. Global PD-L1 and PIK3CA Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 17. The Top 10 and 5 Players Market Share by PD-L1 and PIK3CA Testing Revenue in 2024
 Figure 18. North America PD-L1 and PIK3CA Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America PD-L1 and PIK3CA Testing Market Share by Country (2020-2031)
 Figure 20. United States PD-L1 and PIK3CA Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada PD-L1 and PIK3CA Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe PD-L1 and PIK3CA Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe PD-L1 and PIK3CA Testing Market Share by Country (2020-2031)
 Figure 24. Germany PD-L1 and PIK3CA Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France PD-L1 and PIK3CA Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. PD-L1 and PIK3CA Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy PD-L1 and PIK3CA Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia PD-L1 and PIK3CA Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Ireland PD-L1 and PIK3CA Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific PD-L1 and PIK3CA Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific PD-L1 and PIK3CA Testing Market Share by Region (2020-2031)
 Figure 32. China PD-L1 and PIK3CA Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan PD-L1 and PIK3CA Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea PD-L1 and PIK3CA Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia PD-L1 and PIK3CA Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India PD-L1 and PIK3CA Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia & New Zealand PD-L1 and PIK3CA Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America PD-L1 and PIK3CA Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America PD-L1 and PIK3CA Testing Market Share by Country (2020-2031)
 Figure 40. Mexico PD-L1 and PIK3CA Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil PD-L1 and PIK3CA Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa PD-L1 and PIK3CA Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa PD-L1 and PIK3CA Testing Market Share by Country (2020-2031)
 Figure 44. Israel PD-L1 and PIK3CA Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia PD-L1 and PIK3CA Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE PD-L1 and PIK3CA Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Agilent Technologies Revenue Growth Rate in PD-L1 and PIK3CA Testing Business (2020-2025)
 Figure 48. Roche Revenue Growth Rate in PD-L1 and PIK3CA Testing Business (2020-2025)
 Figure 49. QIAGEN Revenue Growth Rate in PD-L1 and PIK3CA Testing Business (2020-2025)
 Figure 50. EntroGen Revenue Growth Rate in PD-L1 and PIK3CA Testing Business (2020-2025)
 Figure 51. Amoy Diagnostics Revenue Growth Rate in PD-L1 and PIK3CA Testing Business (2020-2025)
 Figure 52. ACCB Biotech Revenue Growth Rate in PD-L1 and PIK3CA Testing Business (2020-2025)
 Figure 53. Bottom-up and Top-down Approaches for This Report
 Figure 54. Data Triangulation
 Figure 55. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

PD L1 and PIK3CA Testing Product Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global PD L1 Biomarker Testing Market Insights Forecast to 2030
Global PD L1 Biomarker Testing Platform Market Insights Forecast to 2030
Global PD 1 PD L1 Checkpoint Inhibitors Market Research Report 2024
Global PD 1 and PDL 1 Inhibitors Market Research Report 2025
Global PDL1 Antibody Reagent Immunohistochemistry Market Research Report 2024
IHC Detection Kits Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pd 1 and Pd L1 Inhibitors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Checkpoint Inhibitors for Treating Cancer Market Insights Forecast to 2030
Immunohistochemistry Transmitter Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Immune Checkpoint Inhibitors for Cancer Market Research Report 2024
Global PD 1 and PD L1 Monoclonal Antibody Market Research Report 2025
Immunohistochemistry IHC Antigen Retrieval Solution Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Combination Antibody Therapy Market Research Report 2024
Immuno Oncology Assays Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
PD 1 and PD L1 Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Immuno Oncology Assays Kit Market Insights Forecast to 2030
Global Automated IHC Staining System Market Research Report 2024
Global Immunoglobulin G Antibody Therapeutics Market Insights Forecast to 2030
Global Immunohistochemistry IHC Testing Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions